SoftBank and Nirma Sell Stakes in Lenskart and Alivus Life Sciences via Block Deals
SoftBank Group sold a 1.56% stake in Lenskart Solutions worth approximately Rs 1,896 crore through block deals on November 6, with institutional investors like Goldman Sachs and Societe Generale among the buyers. Meanwhile, Nirma Limited, promoter of Alivus Life Sciences, offloaded a 2.3% stake valued at around Rs 390 crore at Rs 1,370 per share. Both transactions involved multiple domestic and global investors, with Lenskart shares closing slightly higher and Alivus shares declining amid active trading.
First-hand measurement across 3 sources
We measured how 3 outlets covered this story. No outlet gave this story a measurable political slant — there is no left–right reading to report. Overall sentiment is neutral (58/100). Lens Score 55/100.
Outlets measured: moneycontrol, economictimes, economictimes. See how each one headlined and framed the same story in the source comparison below.
AI Analysis
Sentiment was consistent across outlets (50–70/100), indicating broadly factual reporting rather than editorialising.
Coverage timeline
economictimes broke this story on 6 Nov, 03:31 pm. Other outlets followed.